Cargando…
Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
[Image: see text] A synthesis strategy for the swift generation of 4″-modified α-galactosylceramide (α-GalCer) analogues is described, establishing a chemical platform to comprehensively investigate the structure–activity relationships (SAR) of this understudied glycolipid part. The strategy relies...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467197/ https://www.ncbi.nlm.nih.gov/pubmed/28626526 http://dx.doi.org/10.1021/acsmedchemlett.7b00107 |
_version_ | 1783243222693183488 |
---|---|
author | Janssens, Jonas Decruy, Tine Venken, Koen Seki, Toshiyuki Krols, Simon Van der Eycken, Johan Tsuji, Moriya Elewaut, Dirk Van Calenbergh, Serge |
author_facet | Janssens, Jonas Decruy, Tine Venken, Koen Seki, Toshiyuki Krols, Simon Van der Eycken, Johan Tsuji, Moriya Elewaut, Dirk Van Calenbergh, Serge |
author_sort | Janssens, Jonas |
collection | PubMed |
description | [Image: see text] A synthesis strategy for the swift generation of 4″-modified α-galactosylceramide (α-GalCer) analogues is described, establishing a chemical platform to comprehensively investigate the structure–activity relationships (SAR) of this understudied glycolipid part. The strategy relies on a late-stage reductive ring-opening of a p-methoxybenzylidene (PMP) acetal to regioselectively liberate the 4″-OH position. The expediency of this methodology is demonstrated by the synthesis of a small yet diverse set of analogues, which were tested for their ability to stimulate invariant natural killer T-cells (iNKT) in vitro and in vivo. The introduction of a p-chlorobenzyl ether yielded an analogue with promising immunostimulating properties, paving the way for further SAR studies. |
format | Online Article Text |
id | pubmed-5467197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-54671972018-06-08 Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues Janssens, Jonas Decruy, Tine Venken, Koen Seki, Toshiyuki Krols, Simon Van der Eycken, Johan Tsuji, Moriya Elewaut, Dirk Van Calenbergh, Serge ACS Med Chem Lett [Image: see text] A synthesis strategy for the swift generation of 4″-modified α-galactosylceramide (α-GalCer) analogues is described, establishing a chemical platform to comprehensively investigate the structure–activity relationships (SAR) of this understudied glycolipid part. The strategy relies on a late-stage reductive ring-opening of a p-methoxybenzylidene (PMP) acetal to regioselectively liberate the 4″-OH position. The expediency of this methodology is demonstrated by the synthesis of a small yet diverse set of analogues, which were tested for their ability to stimulate invariant natural killer T-cells (iNKT) in vitro and in vivo. The introduction of a p-chlorobenzyl ether yielded an analogue with promising immunostimulating properties, paving the way for further SAR studies. American Chemical Society 2017-05-05 /pmc/articles/PMC5467197/ /pubmed/28626526 http://dx.doi.org/10.1021/acsmedchemlett.7b00107 Text en This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Janssens, Jonas Decruy, Tine Venken, Koen Seki, Toshiyuki Krols, Simon Van der Eycken, Johan Tsuji, Moriya Elewaut, Dirk Van Calenbergh, Serge Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues |
title | Efficient Divergent Synthesis of New Immunostimulant
4″-Modified α-Galactosylceramide Analogues |
title_full | Efficient Divergent Synthesis of New Immunostimulant
4″-Modified α-Galactosylceramide Analogues |
title_fullStr | Efficient Divergent Synthesis of New Immunostimulant
4″-Modified α-Galactosylceramide Analogues |
title_full_unstemmed | Efficient Divergent Synthesis of New Immunostimulant
4″-Modified α-Galactosylceramide Analogues |
title_short | Efficient Divergent Synthesis of New Immunostimulant
4″-Modified α-Galactosylceramide Analogues |
title_sort | efficient divergent synthesis of new immunostimulant
4″-modified α-galactosylceramide analogues |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467197/ https://www.ncbi.nlm.nih.gov/pubmed/28626526 http://dx.doi.org/10.1021/acsmedchemlett.7b00107 |
work_keys_str_mv | AT janssensjonas efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT decruytine efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT venkenkoen efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT sekitoshiyuki efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT krolssimon efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT vandereyckenjohan efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT tsujimoriya efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT elewautdirk efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues AT vancalenberghserge efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues |